When less is more - efficacy with less toxicity at the ED50
Br J Clin Pharmacol
.
2017 Jul;83(7):1365-1368.
doi: 10.1111/bcp.13281.
Epub 2017 Apr 6.
Authors
Simon Dimmitt
1
2
,
Hans Stampfer
3
4
,
Jennifer H Martin
5
6
Affiliations
1
School of Medicine & Pharmacology, University of Western Australia, 3/10 McCourt St, West Leederville, 6007, Australia.
2
Australian Community & Health Foundation, West Leederville, 6007, Australia.
3
Joondalup Health Campus, The University of Western Australia, Crawley, WA, 6009, Australia.
4
Consultant Psychiatrist, Sir Charles Gairdner Hospital, Perth, WA, Australia.
5
University of Newcastle School of Medicine and Public Health, Callaghan, New South Wales, 2298, Australia.
6
Department of Medicine, Hunter New England Local Health District, Newcastle, Australia.
PMID:
28387051
PMCID:
PMC5465328
DOI:
10.1111/bcp.13281
No abstract available
Keywords:
dose-response; effective dose 50; pharmaceutical marketing.
Publication types
Editorial
MeSH terms
Clinical Trials as Topic
Dose-Response Relationship, Drug*
Evidence-Based Practice
Humans